Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Summary: Background: There is no effective treatment for women with unexplained recurrent pregnancy loss (RPL). We aimed to investigate whether treatment with a high dose of intravenous immunoglobulin (IVIG) in early pregnancy can improve pregnancy outcomes in women with unexplained RPL. Methods: I...

Full description

Bibliographic Details
Main Authors: Hideto Yamada, Masashi Deguchi, Shigeru Saito, Toshiyuki Takeshita, Mari Mitsui, Tsuyoshi Saito, Takeshi Nagamatsu, Koichi Takakuwa, Mikiya Nakatsuka, Satoshi Yoneda, Katsuko Egashira, Masahito Tachibana, Keiichi Matsubara, Ritsuo Honda, Atsushi Fukui, Kanji Tanaka, Kazuo Sengoku, Toshiaki Endo, Hiroaki Yata
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:EClinicalMedicine
Subjects:
Abortion
Intravenous immunoglobulin
Pregnancy outcome
Recurrent miscarriage
Recurrent pregnancy loss
Unknown aetiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022002577

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022002577

Similar Items